Celiac Disease: A Forty-Year Analysis in an Italian Referral Center.

celiac disease clinical features natural history osteoporosis refractory celiac disease

Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
17 Jul 2024
Historique:
received: 25 06 2024
revised: 13 07 2024
accepted: 15 07 2024
medline: 27 7 2024
pubmed: 27 7 2024
entrez: 27 7 2024
Statut: epublish

Résumé

Celiac disease (CD) is an autoimmune disorder triggered by gluten ingestion. Herein, we assessed clinical, serological and histopathological findings of a single-center, large cohort of CD patients diagnosed and followed-up over forty years. From January 1980 to December 2020, 1547 CD patients (1170 females; age range: 8-81 years; F:M ratio = 3.1:1) were diagnosed in an Italian tertiary referral center. Comorbidities and complications were recorded at diagnosis and during follow-up. CD diagnoses quadrupled after 2000. The most frequent phenotype was the non-classical CD (63.3%), and the most prevalent histotype was Marsh 3C (44.7%). Gastrointestinal manifestations, detectable in 51% of patients, were diarrhea (24.3%), bloating (28%) and aphthous stomatitis (19.7%). The most common CD-associated disorder was osteopenia (59.9%), predominant in females (64.3%); extraintestinal manifestations included anemia (35.8% iron-deficiency; 87% folic acid malabsorption), cryptogenic hypertransaminasemia (27.9%), and recurrent miscarriages (11.5%). Thyroiditis (26.9%), type 1 diabetes mellitus (2.9%), and dermatitis herpetiformis (1.4%) were the most common CD-related autoimmune disorders. Six patients had inflammatory bowel disease. Complications and mortality rate occurred in 1.8% and 1.9%, respectively. This single-center, large cohort analysis confirmed that CD presentation changed over the years, with an increase of non-classical and subclinical clinical phenotypes.

Sections du résumé

BACKGROUND BACKGROUND
Celiac disease (CD) is an autoimmune disorder triggered by gluten ingestion. Herein, we assessed clinical, serological and histopathological findings of a single-center, large cohort of CD patients diagnosed and followed-up over forty years.
METHODS METHODS
From January 1980 to December 2020, 1547 CD patients (1170 females; age range: 8-81 years; F:M ratio = 3.1:1) were diagnosed in an Italian tertiary referral center. Comorbidities and complications were recorded at diagnosis and during follow-up.
RESULTS RESULTS
CD diagnoses quadrupled after 2000. The most frequent phenotype was the non-classical CD (63.3%), and the most prevalent histotype was Marsh 3C (44.7%). Gastrointestinal manifestations, detectable in 51% of patients, were diarrhea (24.3%), bloating (28%) and aphthous stomatitis (19.7%). The most common CD-associated disorder was osteopenia (59.9%), predominant in females (64.3%); extraintestinal manifestations included anemia (35.8% iron-deficiency; 87% folic acid malabsorption), cryptogenic hypertransaminasemia (27.9%), and recurrent miscarriages (11.5%). Thyroiditis (26.9%), type 1 diabetes mellitus (2.9%), and dermatitis herpetiformis (1.4%) were the most common CD-related autoimmune disorders. Six patients had inflammatory bowel disease. Complications and mortality rate occurred in 1.8% and 1.9%, respectively.
CONCLUSIONS CONCLUSIONS
This single-center, large cohort analysis confirmed that CD presentation changed over the years, with an increase of non-classical and subclinical clinical phenotypes.

Identifiants

pubmed: 39064734
pii: nu16142292
doi: 10.3390/nu16142292
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Lisa Lungaro (L)

Department of Translational Medicine, St. Anna Hospital, University of Ferrara, 44124 Ferrara, Italy.

Anna Costanzini (A)

Department of Translational Medicine, St. Anna Hospital, University of Ferrara, 44124 Ferrara, Italy.

Francesca Manza (F)

Department of Translational Medicine, St. Anna Hospital, University of Ferrara, 44124 Ferrara, Italy.

Fabio Caputo (F)

Department of Translational Medicine, St. Anna Hospital, University of Ferrara, 44124 Ferrara, Italy.

Francesca Remelli (F)

Department of Medical Science, University of Ferrara, 44124 Ferrara, Italy.

Stefano Volpato (S)

Department of Medical Science, University of Ferrara, 44124 Ferrara, Italy.
Geriatrics Unit, Azienda Ospedaliero-Universitaria of Ferrara, 44124 Ferrara, Italy.

Roberto De Giorgio (R)

Department of Translational Medicine, St. Anna Hospital, University of Ferrara, 44124 Ferrara, Italy.

Umberto Volta (U)

Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.

Giacomo Caio (G)

Department of Translational Medicine, St. Anna Hospital, University of Ferrara, 44124 Ferrara, Italy.
Mucosal Immunology and Biology Research Center, Massachusetts General Hospital-Harvard Medical School, Boston, MA 02114, USA.

Classifications MeSH